Single-dose, 2-way crossover, bioequivalence study of dexmethylphenidate with and without food in healthy subjects.

被引：0
|
作者：
Teo, S [1 ]
Scheffler, M [1 ]
Stirling, D [1 ]
Thomas, S [1 ]
Khetani, V [1 ]
机构：
[1] Celgene Corp, Warren, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90489-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P36 / P36
页数：1
相关论文
共 50 条
  • [21] Bioequivalence and Food Effect Assessment of 2 Rivaroxaban Formulations in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, and 4-Period Crossover Study
    Tao, Ye
    Jiang, Xin
    Shi, Ping
    Liu, Yanping
    Lin, Pingping
    Liu, Shuqin
    Li, Ting
    Ma, Yaping
    Gao, Xiaomeng
    Cao, Yu
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (03): : 358 - 363
  • [22] Single-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.
    Bartlett, M.
    Vaidyanathan, S.
    Karan, R. S.
    Hu, P.
    Howard, D.
    Yeh, C. M.
    Dieterich, H. A.
    Al-Fayoumi, S.
    Jarugula, V.
    Doles, W. P.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S62 - S62
  • [23] An Open-Label, Randomized, 2-Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers
    Lai, Xiuping
    Ye, Suiwen
    Chen, Liuhan
    Chen, Junyi
    Zhang, Nan
    Zhang, Yiwen
    Wu, Junyan
    Yao, Herui
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (12): : 1478 - 1484
  • [24] A Randomized, Double-Blind, Single-Dose, Crossover Study to Demonstrate the Bioequivalence of 2 Formulations of Albiglutide in Healthy Adult Participants
    Shaddinger, Bonnie C.
    Vlasakakis, Georgios
    Soifer, Joseph
    Thorpe, Karl M.
    Hatch, Daniel
    Nino, Antonio J.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03): : 361 - 370
  • [25] Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single-Dose Administration in Healthy Chinese Subjects
    Ye, Libing
    Shen, Minmin
    Chen, Yingrong
    Li, Xiaofeng
    Xu, Min
    Yao, Chong
    Yang, Shuixin
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1084 - 1091
  • [26] Bioequivalence and pharmacokinetics of two zidovudine formulations in healthy Brazilian volunteers: An open-label, randomized, single-dose, two-way crossover study
    dos Reis Serra, Cristina Helena
    Mori Koono, Eunice Emiko
    Kano, Eunice Kazue
    Schramm, Simone Grigoleto
    Armando, Yara Popst
    Porta, Valentina
    [J]. CLINICAL THERAPEUTICS, 2008, 30 (05) : 902 - 908
  • [27] A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects
    Xu, Zhongnan
    Wang, Yanli
    Liu, Guangwen
    Chen, Jiahui
    Wang, Wanhua
    Cheng, Yang
    Ren, Qing
    Cui, Yingzi
    Yang, Wei
    Liu, Zhengzhi
    Chen, Xuesong
    Xue, Jinling
    Chang, Tianying
    Qu, Xinyao
    Yu, Shuang
    Zhou, Yannan
    Xu, Kaibo
    Su, Zhengjie
    Deng, Qiaohuan
    Zhao, Yicheng
    Yang, Haimiao
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (07) : 737 - 746
  • [28] A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults
    Sikes, Carolyn
    Stark, Jeffrey G.
    McMahen, Russ
    Engelking, Dorothy
    [J]. JOURNAL OF ATTENTION DISORDERS, 2020, 24 (03) : 414 - 419
  • [29] Randomized, single-blind, crossover study to assess the pharmacokinetic and pharmacodynamic bioequivalence of CHS-1701 to pegfilgrastim in healthy subjects.
    Glaspy, John A.
    O'Connor, Paula G.
    Tang, Hong
    Finck, Barbara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers
    Wang, Shumin
    Wu, Feng
    Han, Ying
    Ni, Siyang
    Guo, Shaojie
    Dai, Yuyang
    Xia, Qiang
    Chang, Di
    Zhang, Ju
    Wei, Huiwen
    Zhao, Xiuli
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956
12345